Hydrochloric Acid

Hydrochloric Acid

SCHEMBL668151

C[n+]1c2ccccc2c(-c2c3ccccc3[n+](C)c3ccccc23)c2ccccc21.Cl.O=[N+]([O-])[O-].O=[N+]([O-])[O-]

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 16/20 0.57
S1PR4 known ✓ O95977 1/20 0.41
S1PR1 known ✓ P21453 1/20 0.41
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.41
MAPT P10636 1/20 0.41
HTT P42858 1/20 0.41
RAB9A P51151 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29240 0.98 ACHE (0.59) ACHEKDM4ENPC1S1PR4MAPT
SCHEMBL29562542 0.98 ACHE (0.59) ACHEKDM4ENPC1S1PR4MAPT
Nitric Acid SCHEMBL29563050 0.90 ACHE (0.55) ACHEKDM4ENPC1S1PR4MAPT
SCHEMBL3972008 0.85 ACHE (0.74) ACHE
SCHEMBL29411838 0.85 ACHE (0.74) ACHE
SCHEMBL4670865 0.77 MAPT (0.39) ACHEKDM4ENPC1S1PR4MAPT
SCHEMBL7091234 0.76 ALDH1A1 (0.57) ACHEKDM4ENPC1S1PR4MAPT
SCHEMBL19329417 0.73 ATM (0.50) ACHEKDM4ENPC1S1PR4MAPT
SCHEMBL2315874 0.73 ATM (0.50) ACHEKDM4ENPC1S1PR4MAPT
SCHEMBL6904073 0.72 ACHE (1.00) ACHERAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8193315-B2 Excitatory glycine receptors and methods SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2012-06-05 US disclosed
US-20120046446-A1 p16 MEDIATED REGULATION OF NMDA RECEPTORS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2012-02-23 US disclosed
US-20110045098-A1 EXCITATORY GLYCINE RECEPTORS AND METHODS SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2011-02-24 US disclosed
US-7790404-B2 Excitatory glycine receptors and methods SANFORD-BURNHAM MEDICAL RESEARCH INSTITUTE (US) 2010-09-07 US disclosed
US-20100160607-A1 p16 MEDIATED REGULATION OF NMDA RECEPTORS NATIONAL INSTITUTES OF HEALTH - DIRETOR DEITR 2010-06-24 US disclosed
US-7544478-B2 Method for screening for compounds that modulate P16 mediated regulation of NMDA receptors THE BURNHAM INSTITUTE (US) 2009-06-09 US disclosed
EP-1660634-A4 P16 MEDIATED REGULATION OF NMDA RECEPTORS BURNHAM INST (US) 2009-02-18 EP disclosed
EP-1578909-A4 EXCITATORY GLYCINE RECEPTORS AND METHODS BURNHAM INST (US) 2007-09-26 EP disclosed
EP-1660634-A2 P16 MEDIATED REGULATION OF NMDA RECEPTORS The Burnham Institute (US) 2006-05-31 EP disclosed
EP-1578909-A2 EXCITATORY GLYCINE RECEPTORS AND METHODS The Burnham Institute (US) 2005-09-28 EP disclosed
US-20050037433-A1 p16 mediated regulation of NMDA receptors NATIONAL INSTITUTES OF HEALTH - DIRECTOR DEITR 2005-02-17 US disclosed
WO-2005014797-A2 P16 MEDIATED REGULATION OF NMDA RECEPTORS THE BURNHAM INSTITUTE (US) 2005-02-17 WO disclosed
US-20040033500-A1 Excitatory glycine receptors and methods THE BURNHAM INSTITUTE 2004-02-19 US disclosed
US-20030092004-A1 Excitatory glycine receptors and methods LIPTON STUART A (US) 2003-05-15 US disclosed
WO-2003016479-A2 EXCITATORY GLYCINE RECEPTORS AND METHODS THE BURNHAM INSTITUTE (US) 2003-02-27 WO disclosed